Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Hundreds Were Mistakenly Told They Might Have Cancer, Test Company Says

Grail, which makes a blood test for cancer, said a vendor’s software issue caused inaccurate letters to be sent to about 400 customers last month.

Amanda Holpuch
Author: Amanda Holpuch

Written by

Amanda Holpuch

in

Antitrust Laws and Competition Issues, Cancer, Federal Trade Commission, Grail Inc, Illumina Inc, Mergers, Acquisitions and Divestitures, Tests (Medical)
←Saudi Arabia Says It Will Cut Production to Stem a Slide in Oil Prices
Lily-Rose Depp Reveals She Tries To ‘Steer Clear’ Of The Weeknd On ‘The Idol’ Set→

More posts

  • Protesters, leaders push back against DHS over Newark detention facility conditions

  • Goldman and Lander spar hard over Israel

  • Snowflake climbs after Q1 results top expectations, guidance gets a boost

  • Synopsys drops despite better than expected Q2 results, big boost to full-year guidance

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube